Quest Diagnostics (NY:DGX)

230.09 -1.00 (-0.43%)

Delayed Quote Updated: 9:40 AM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Quest Diagnostics

< Previous 1 2 Next >

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States

September 24, 2025

From Guardant Health, Inc.

Via Business Wire

WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App

September 18, 2025

From WHOOP

Via Business Wire

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

December 19, 2024

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA Approval

From Mainz BioMed NV

Via GlobeNewswire

Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard

August 28, 2023

Via ACCESSWIRE

Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy

July 18, 2024

From Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology

Via GlobeNewswire

Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests

June 18, 2024

Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including

Via MarketBeat

Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX

April 30, 2024

Via AB Newswire

LifeMD Shares Come Back to Life on GLP-1 Business Growth

March 19, 2024

LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024

Via MarketBeat

Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing

January 09, 2024

From Ultima Genomics

Via Business Wire

Quest Diagnostics Inc. (NYSE: DGX) Highlighted for Surprising Price Action

December 12, 2023

Via Investor Brand Network

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

October 17, 2023

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

Exact Sciences Serves Investors Exactly What They Wished For

May 15, 2023

Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The

Via MarketBeat

UiPath is a Cheaper and More Profitable AI Stock

April 06, 2023

With the mainstream popularity of ChatGPT, artificial intelligence (AI) has been all the rage in 2023. The AI wars between Microsoft Co. (NASDAQ: MSFT) invest

Via MarketBeat

Topics Artificial Intelligence

Quest Diagnostics Inc. (NYSE: DGX) Making Surprising Moves in Friday Session

March 24, 2023

Via Investor Brand Network

DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test

November 15, 2022

From DermTech, Inc.

Via Business Wire

Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio

October 31, 2022

Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022.

Via MarketBeat

Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards

September 14, 2022

From Achievers

Via Business Wire

Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide

July 19, 2022

From Rite Aid Corporation

Via Business Wire

Quest Diagnostics CHRO Receives "CHRO Lifetime Achievement Award"

June 07, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

ConferMED Awarded Grant From the Quest Diagnostics Foundation To Provide Specialty eConsults to Front Line Providers at Federally Qualified Health Centers in Key Regions

June 03, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Quest for Health Equity Offers No Cost Wellness Screenings at Baltimore Community Event

June 01, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Quest Diagnostics Incorporated (NYSE:DGX) Shareholder Notice: Investigation over Potential Wrongdoing ↗

May 12, 2022

San Diego, CA -- (SBWIRE) -- 05/12/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Quest Diagnostics Incorporated.

Via SBWire

Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence

April 21, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Quest Diagnostics Incorporated (NYSE:DGX) Investor Notice: Investigation over Possible Securities Laws Violations ↗

March 23, 2022

San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Quest Diagnostics Incorporated was under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year

February 03, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market

February 16, 2022

Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years....

Via FinancialNewsMedia

Walmart and Quest Diagnostics Empower People to Take Control of Their Healthcare Through New Consumer-Initiated Laboratory Testing Solution Powered by QuestDirect™ Through Walmart.com

February 02, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Sixth Consecutive Year

January 31, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Project HOPE Awarded Grant to Reduce Transmission of COVID-19 Variants in Long-term Care Facilities

January 26, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Quest Diagnostics Earns Gold Status in American Heart Association's 2021 Workplace Health Achievement Index

December 16, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.